KFA
CBPO

Krane Funds Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Krane Funds Advisors’s Portfolio CBPO Stock Details CBPO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-121
Closed -$14K – 375
2021
Q1 		$14K Hold
121
– – ﹤0.01% 284
2020
Q4 		$14K Buy
121
+35
+41% +$4.07K ﹤0.01% 288
2020
Q3 		$10K Buy
86
+43
+100% +$4.62K ﹤0.01% 226
2020
Q2 		$4K Sell
43
-19
-31% -$2.03K ﹤0.01% 241
2020
Q1 		$7K Hold
62
– – ﹤0.01% 219
2019
Q4 		$7K Sell
62
-32
-34% -$3.71K ﹤0.01% 220
2019
Q3 		$11K Hold
94
– – ﹤0.01% 213
2019
Q2 		$9K Sell
94
-412
-81% -$38.8K ﹤0.01% 206
2019
Q1 		$46.2K Buy
506
+33
+7% +$2.7K ﹤0.01% 77
2018
Q4 		$36 Buy
473
+329
+228% +$24.2K ﹤0.01% 78
2018
Q3 		$13K Buy
+144
New +$13.4K ﹤0.01% 77

Krane Funds Advisors's CBPO Position: Q2 2021 in Review

Krane Funds Advisors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 121 shares — an estimated $14K sold.

Krane Funds Advisors first reported a position in CBPO in Q3 2018 and held it in 11 quarters. The position peaked at $46.2K in Q1 2019. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.

  • Krane Funds Advisors reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
  • Krane Funds Advisors sold 121 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $14K.
  • Krane Funds Advisors first reported a position in China Biologic Products Holdings, Inc. in Q3 2018 and held it in 11 quarters.
  • Krane Funds Advisors's China Biologic Products Holdings, Inc. position peaked at $46.2K in Q1 2019.
  • 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.

Based on Krane Funds Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.